Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2025 Earnings Call Transcript

SABESP held its Q4 and full-year 2025 earnings call on March 17, 2026, with CEO Carlos Piani and CFO Daniel Szlak presenting. The excerpt contains the opening remarks and a standard forward-looking statements disclaimer; no financial results, metrics, or guidance were included in the provided text.

Analysis

SABESP’s story is less about near-term volume noise and more about a regulated cash flow stream whose true value compounds as tariff resets, capex recognition and inflation indexation catch up. The key second-order mechanism is timing: delayed tariff approvals and indexation lags create temporary working-capital stress that depresses near-term earnings, but they also concentrate upside into the next 6–18 months when regulatory adjustments and the RAB (regulated asset base) re-pricing materialize. That creates convexity — asymmetric payoff where downside from one bad quarter is limited but upside from a successful tariff/capex recognition cycle is multi-quarter and persistent.

A non-obvious beneficiary chain runs from SABESP’s capex to its suppliers and digital metering vendors: increased investment in leakage reduction and network upgrades locks in service quality gains, reduces NRW (non-revenue water) and increases billability over a multi-year horizon, boosting cash conversion. Conversely, short-cycle construction and materials names will feel margin pressure if SABESP shifts more toward O&M and tech-driven fixes vs large civil works. Funding conditions (Brazil sovereign spreads and local rates) are the multiplier: a 100–200bp move in Selic or sovereign spread materially changes NPV of future regulated returns and the company’s incentive to accelerate or defer projects.

Regulatory decisions (ARSESP/state-level approvals) and hydrology are the two primary catalysts in the next 3–12 months; political noise around state budgets or judicial interference is the main tail risk that could permanently compress allowed returns. The market’s consensus focus on quarterly volumes understates that a tariff re-set or a tranche of recognized capex can re-rate equity by 20–40% over 6–12 months if realized — the contrarian read is that short-term weakness is a buying opportunity, not a structural impairment.

Key Decisions for Investors

• Long SBS equity (conviction buy) on a >10% post-earnings pullback, size 3–5% of portfolio, horizon 6–12 months. Rationale: asymmetric payoff from tariff/capex re-pricing; target 25–40% upside, stop-loss -12% to limit regulatory tail risk.
• Buy SBS local-currency debentures vs. Brazil sovereign duration (relative credit play) if spread to sovereign exceeds 120–150bps; horizon 12–36 months. Risk/reward: coupon carry + expected spread tightening if tariff visibility improves; tail risk is sovereign/market widening that re-prices both.
• Long-dated call exposure: buy SBS Jan-2028 calls or a 2-year call spread to capture re-rating while limiting premium spend. Position size small (1–2% of portfolio) as convexity play; payoff large if regulatory approvals and capex recognition occur within 12–24 months.
• Pair trade to isolate regulated vs cyclicals: long SBS / short EWZ (or a Brazil cyclicals basket) — horizon 3–9 months. This reduces macro beta and monetizes SABESP’s regulatory re-rating while hedging broader Brazil risk; unwind if sovereign spreads widen >100bps or rainfall normalizes demand materially.